세계의 약물 남용 치료 시장 : 유형별, 치료 유형별, 연령층별, 치료 환경별, 지역별

Global Substance Abuse Treatment Market is estimated to be valued at USD 11.82 Bn in 2025 and is expected to reach USD 21.33 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Figure. Global Substance Abuse Treatment Market Share (%), By Region 2025

Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.

Market Dynamics:

Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global substance abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global substance abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.

Detailed Segmentation:

• Global Substance Abuse Treatment Market, By Type
  • Alcohol
  • Opioids (e.g., heroin, prescription painkillers)
  • Tobacco/nicotine
  • Cocaine
  • Marijuana
  • Methamphetamines
  • Other illicit drugs (Benzodiazepines, etc.)
• Global Substance Abuse Treatment Market, By Treatment Type
  • Opioid
  • Methadone
  • Buprenorphine
  • Extended-release naltrexone
  • Lofexidine
  • Nicotine
  • Nicotine replacement therapies (available as a patch, inhaler, or gum)
  • Bupropion
  • Varenicline
  • Alcohol
  • Naltrexone
  • Disulfiram
  • Acamprosate
  • Tobacco
  • Clonidine
  • Nortriptyline
  • Others (Topiramate, Modafinil, etc.)
• Global Substance Abuse Treatment Market, By Age Group
  • Adolescents
  • Adults
  • Geriatric
• Global Substance Abuse Treatment Market, By Treatment Setting
  • Outpatient Treatment
  • Outpatient Clinics
  • Private Practices
  • Inpatient Treatment
  • Rehabilitation Centers
  • Hospitals
  • Residential Treatment Facilities
  • Detoxification Centers
• Global Substance Abuse Treatment Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Indivior PLC
  • Pfizer, Inc.
  • Johnson & Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Treatment Type
  • Market Snippet, By Age Group
  • Market Snippet, By Treatment Setting
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers:
• Increasing consumption of drugs and alcohol
• Growing support from government and NGOs
  • Restraints
• Social stigma associated with substance dependence
• Lack of adequate rehabilitation facilities
  • Opportunities
• Untapped markets in developing countries
• Company Market Share Analysis
• Key Highlights
• Market Trends
• PEST Analysis
• PORTER's Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations

4. Global Substance Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Substance Abuse Treatment Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Alcohol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Opioids (e.g., heroin, prescription painkillers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Tobacco/nicotine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cocaine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Marijuana
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Methamphetamines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other illicit drugs (Benzodiazepines, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Substance Abuse Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Opioid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Methadone
• Buprenorphine
• Extended-release naltrexone
• Lofexidine
• Nicotine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Nicotine replacement therapies (available as a patch, inhaler, or gum)
• Bupropion
• Varenicline
• Alcohol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Naltrexone
• Disulfiram
• Acamprosate
• Tobacco
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Clonidine
• Nortriptyline
• Others (Topiramate, Modafinil, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Substance Abuse Treatment Market, By Age Group, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adolescents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Substance Abuse Treatment Market, By Treatment Setting, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Outpatient Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Outpatient Clinics
• Private Practices
• Inpatient Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Rehabilitation Centers
• Hospitals
• Residential Treatment Facilities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Detoxification Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Substance Abuse Treatment Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Indivior PLC
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer, Inc.
  • Johnson & Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players
• Analyst Views

11. Section

• References
• Research Methodology
• About us